Short- Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
- 1 March 2015
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 65 (11), 1092-1102
- https://doi.org/10.1016/j.jacc.2014.12.046
Abstract
No abstract availableKeywords
Funding Information
- St. Jude Medical
- Abbott Vascular
- Eli Lilly and Company
- Medtronic
This publication has 30 references indexed in Scilit:
- Duration of Dual Antiplatelet Therapy and Long-Term Clinical Outcome After Coronary Drug-Eluting Stent ImplantationCirculation: Cardiovascular Interventions, 2012
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary StentingCirculation, 2012
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2011
- Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting StentsNew England Journal of Medicine, 2010
- Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent ImplantationCirculation, 2009
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- A Cause for ConcernCirculation, 2007
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting StentsJournal of the American College of Cardiology, 2006
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCell Metabolism, 2006
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004